Resistance profile survey of 50 periodontal strains of actinobacillus actinomycetemcomitans

Journal of Periodontology

Volumn 70, Issue 8, 1999, Pages 888-892

  Madinier, Isabelle M ^a,b   Fosse, Thierry B ^a,c   Hitzig, Claude ^d   Charbit, Yves ^d   Hannoun, Lionel R ^d  

^a UNIVERSITY HOSPITAL OF NICE   (France)

^b UNIVERSITÉ CÔTE D'AZUR   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d NONE

Author keywords

Actinobacillus actinomycetemcomitans; Amoxicillin therapeutic use; Beta lactamases; Ciprofloxacin therapeutic use; Clarythromycin therapeutic use; Clavulanic acids therapeutic use; Drug resistance, microbial; Erythromycin therapeutic use; Metronidazole therapeutic use; Ornidazole therapeutic use; Penicillin G therapeutic use; Periodontal pockets microbiology; Periodontitis microbiology; Pristinamycin therapeutic use; Spiramycin therapeutic use; Tetracycline therapeutic use

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; METRONIDAZOLE; ORNIDAZOLE; PENICILLIN G; PRISTINAMYCIN; SPIRAMYCIN; TETRACYCLINE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; DILUTION; HUMAN; PORPHYROMONAS; PREVOTELLA;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ADULT; AMOXICILLIN; AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CIPROFLOXACIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; ORNIDAZOLE; PERIODONTAL POCKET; PERIODONTITIS; SPECIES SPECIFICITY; SPIRAMYCIN; TETRACYCLINE; VIRGINIAMYCIN;

EID: 0032785231     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1999.70.8.888     Document Type: Article

References (41)

1. Slots J, Reynolds HS, Genco RJ. Actinobacillus actinomycetemcomitans in human periodontal disease: a cross sectional microbiological investigation. Infect Immun 1980;29:1013-1020.
2. Zambon JJ. Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol 1985; 12:1-20.
3. Mashimo PA, Yamamoto Y, Slots J, Park BH, Genco RJ. The periodontal microflora of juvenile diabetics: culture, immunofluorescence, and serum antibody studies. J Periodontol 1983;54:420-430.
4. Kaplan AH, Weber DJ, Oddone EZ, Perfect JR. Infection due to Actinobacillus actinomycetemcomitans: 15 cases and review. Rev Infect Dis 1989;11:46-63.
5. Slots J, Rosling BG, Genco RJ. Suppression of penicillin-resistant oral Actinobacillus actinomycetemcomitans with tetracycline. Considerations in endocarditis prophylaxis. J Periodontol 1983;54:193-196.
6. Pajukanta R, Asikainen S, Forsblom B, Saarela M, Jousimies-Somer H. ß-lactamase production and in vitro susceptibility of Porphyromonas gingivalis. FEMS Immunol Med Microbiol 1993;6:241-244.
7. Bollen CM, Quirynen M. Microbiological response to mechanical treatment in combination with adjunctive therapy. A review of the literature. J Periodontol 1996; 67:1143-1158.
8. Meyer DH, Sreenivasan PK, Fives-Taylor PM. Evidence for invasion of a human oral cell line by Actinobacillus actinomycetemcomitans. Infect Immun 1991;59:2719-2726.
9. Christersson LA, Zambon JJ. Suppression of subgingival Actinobacillus actinomycetemcomitans in localized juvenile periodontitis by systemic tetracycline. J Clin Periodontol 1993;20:395-401.
10. Tinoco EM, Beldi MI, Campedelli F, et al. Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial. J Periodontol 1998;69:1355-1365.
11. Bush K. The evolution of ß-lactamases. In: Antibiotic Resistance: Origins, Evolution, Selection and Spread. (Ciba Foundation, Symposium 207). Chicester, UK: John Wiley and Sons; 1997;207:152-166.
12. Medeiros AA. Evolution and dissemination of ß-lactamases accelerated by generations of ß-lactam antibiotics. Clin Infect Dis 1997;24 (Supp. 1):S19-S45.
13. Bernal LA, Guillot E, Paquet C, Mouton C. ß-lactamase producing strains in the species Prevotella intermedia and Prevotella nigrescens. Oral Microbiol Immunol 1998; 3:36-40.
14. Hedberg M, Lindqvist L, Bergman T, Nord CE. Purification and characterization of a new ß-lactamase from Bacteroides uniformis. Antimicrob Agents Chemother 1995;39:1458-1461.
15. Johnson CC, Wendeler M, Levison ME. In vitro susceptibilities of oral pigmented Bacteroides species to trospectomycin and other selected antimicrobial agents. Antimicrob Agents Chemother 1990;34:1597-1599.
16. Kinder SA, Holt SC, Kornman KS. Penicillin resistance in the subgingival microbiota associated with adult periodontitis. J Clin Microbiol 1986;23:1127-1133.
17. Könönen E, Nyfors S, Matto J, Asikainen S, Jousimies-Somer H. Beta-lactamase production by oral pigmented Prevotella species isolated from young children. Clin Infect Dis 1997;25(Suppl. 2): S272-S274.
18. Könönen E, Saarela M, Kanervo A, Karjalainen J, Asikainen S, Jousimies-Somer H. ß-lactamase production and penicillin susceptibility among different ribotypes of Prevotella melaninogenica simultaneously colonizing the oral cavity. Clin Infect Dis 1995;20(Suppl. 2):S364-S366.
19. Lewis MA, Parkhurst CL, Douglas CW, et al. Prevalence of penicillin resistant bacteria in acute suppurative oral infections. J Antimicrob Chemother 1995;35:785-791.
20. van Winkelhoff AJ, Winkel EG, Barendregt D, Delleminj-Kippuw N, Stijne A, van der Velden U. ß-lactamase producing bacteria in adult periodontitis. J Clin Periodontol 1997;24:538-543.
21. Fosse T, Madinier I, Hitzig C, Charbit Y. Prevalence of ß-lactamase producing strains among 149 anerobic Gram-negative rods isolated from periodontal pockets. Oral Microbiol Immunol 1999; in press.
22. Foweralker JE, Hawkey PM, Heritage J, Van Landuyt HW. Novel ß-lactamase from Capnocytophaga sp. Antimicrob Agents Chemother 1990;34:1501-1504.
23. Lacroix JM, Walker C. Characterization of a ß-lactamase found in Eikenella corrodens. Antimicrob Agents Chemother 1991;35:886-891.
24. Roscoe DL, Zemcov JV, Thornber D, Wise R, Clarke AM. Antimicrobial susceptibilities and ß-lactamase characterization of Capnocytophaga species. Antimicrob Agents Chemother 1992;36:2197-2200.
25. Lacroix JM, Walker CB. Detection and prevalence of the tetracycline resistance determinant let Q in the microbiota associated with adult periodontitis. Oral Microbiol Immunol 1996;11:282-288.
26. Slots J, Evans RT, Lobbins PM, Genco RJ. In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 1980;18:9-12.
27. Walker CB, Pappas JD, Tyler KZ, Cohen S, Gordon JM. Antibiotic susceptibilities of periodontal bacteria. In vitro susceptibility to eight antimicrobial agents. J Periodontol 1985;(Suppl.):S67-S74.
28. O'Connor BC, Newman HN, Wilson M. Susceptibility and resistance of plaque bacteria to minocycline. J Periodontol 1990;61:228-233.
29. Listgarten MA, Lai CH, Young V. Microbial composition and pattern of antibiotic resistance in subgingival microbial samples from patients with refractory periodontitis. J Periodontol 1993;64:155-161.
30. Roe DE, Braham PH, Weinberg A, Roberts MC. Characterization of tetracycline resistance in Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1995;10:227-232.
31. Slots J. Salient biochemical characters of Actinobacillus actinomycetemcomitans. Arch Microbiol 1982;131:60-67.
32. Hedberg M, Nord CE. Beta-lactam resistance in anaerobic bacteria: a review. J Chemother 1996;8:3-16.
33. Guiney DG, Bouic K. Detection of conjugal transfer systems in oral, black-pigmented Bacteroides spp. J Bacteriol 1990;172:495-497.
34. Roe DE, Weinberg A, Roberts MC. Mobile rRNA methylase genes coding for erythromycin resistance in Actinobacillus actinomycetemcomitans. J Antimicrob Chemother 1996;37:457-464.
35. Sreenivasan PK, Leblanc DJ, Lee LN, Fives-Taylor P. Transformation of Actinobacillus actinomycetem-comitans by electroporation, utilizing constructed shuttle plasmids. Infect Immun 1991;59:4621-4627.
36. Goncharoff P, Yip JK, Wang H, et al. Conjugal transfer of broad-host-range incompatibility group P and Q plasmids from Escherichia coli to Actinobacillus actinomycetemcomitans. Infect Immun 1993;61:3544-3547.
37. Brogan JM, Lally ET, Dermuth DR. Construction of pYGK, an Actinobacillus actinomycetemcomitans -Escherichia coli shuttle vector. Gene 1996;169:141-142.
38. Nowak KF, Lee LN, Leblanc DJ. Functional analysis of pVT745, a plasmid from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1998; 13:124-128.
39. Olvisk B, Tenover FC. Tetracycline resistance in periodontal pathogens. Clin Infect Dis 1993;16(Suppl. 4):S310-S313.
40. van Winkelhoff AJ, Tijhof CJ, de Graaff J. Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis. J Periodontol 1992;63:52-57.
41. Müller Hp, Heinecke A, Borneff M, Kiencke C, Knopf A, Pohl S. Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis. J Periodont Res 1998;33:49-58.